Ketanserin
| CAS No. | 74050-98-9;83846-83-7 | Cat. No. | BCP02187 |
| Name | Ketanserin | ||
| Synonyms | Perketan;R-49945;R 49945;R49945;Serefrex;Serepress; | ||
| Formula | C22H22FN3O3 | M. Wt | 395.43 |
| Description | Ketanserin inhibits rat and human 5-HT2C with Ki of 50 and100 nM, respectively and has higher affinity binding for alpha-1 adrenergic (Ki = ~ 40 nM) and Histamine H1 (Ki = 2 nM). Ketanserin can also be used to discriminate between 5-HT1D and 5-HT1B receptor subtypes. Ketanserin has antihypertensive properties. Ketanserin also reduces platelet aggregation produced by serotonin. Ketanserin also has high affinity for alpha-1 adrenergic receptors, and very high affinity for histamine H1 receptors. Ketanserin was shown to reduce the severity and frequency of the vasospasm in Raynaud’s phenomenon. | ||
| Pathways | Ion Channel/Membrane Transporter Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | 5 HT Receptor/Serotonin Receptor Potassium Channel | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.